SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-042467
Filing Date
2024-05-14
Accepted
2024-05-13 18:27:54
Documents
76
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0204878-10q_inmedpharma.htm   iXBRL 10-Q 849440
2 SCIENTIFIC ADVISORY BOARD CONSULTING AGREEMENT, DATED AS OF APRIL 12, 2024, BETW ea020487801ex10-1_inmed.htm EX-10.1 13128
3 CERTIFICATION ea020487801ex31-1_inmed.htm EX-31.1 11017
4 CERTIFICATION ea020487801ex31-2_inmed.htm EX-31.2 10987
5 CERTIFICATION ea020487801ex32-1_inmed.htm EX-32.1 3907
6 CERTIFICATION ea020487801ex32-2_inmed.htm EX-32.2 3877
7 GRAPHIC image_001.jpg GRAPHIC 4154
8 GRAPHIC ex10-1_001.jpg GRAPHIC 5102
  Complete submission text file 0001213900-24-042467.txt   5077436

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE inm-20240331.xsd EX-101.SCH 44292
10 XBRL CALCULATION FILE inm-20240331_cal.xml EX-101.CAL 42814
11 XBRL DEFINITION FILE inm-20240331_def.xml EX-101.DEF 228582
12 XBRL LABEL FILE inm-20240331_lab.xml EX-101.LAB 402095
13 XBRL PRESENTATION FILE inm-20240331_pre.xml EX-101.PRE 228299
80 EXTRACTED XBRL INSTANCE DOCUMENT ea0204878-10q_inmedpharma_htm.xml XML 607246
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 24940767
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)